Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
Brief Summary: The purpose of this study is to determine whether alpha-lipoic acid and acetyl-L-carnitine will lower systemic inflammation in patients with Sickle Cell Disease by reducing oxidative stress, which will result in a decrease in the frequency of vaso-occlusive pain episodes and improve their quality of life.